Our results suggest that increased IL-17 and Th2 cytokine production by Hem1-deficient CD4+ T cells may contribute to dermal atopy and asthma, and potentially IBD in Hem1-deficient mice and children. This evidence concerns the gene IL17A and inflammatory bowel disease.